Home/Filings/4/0001415889-22-009880
4//SEC Filing

Bohen Sean 4

Accession 0001415889-22-009880

CIK 0001750284other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 6:51 PM ET

Size

5.0 KB

Accession

0001415889-22-009880

Insider Transaction Report

Form 4
Period: 2022-09-21
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Common Stock

    2022-09-21+20,00074,279 total
Footnotes (2)
  • [F1]The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  • [F2]Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001831218

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 6:51 PM ET
Size
5.0 KB